National Research (NASDAQ:NRC) Announces Earnings Results

Key Points

• National Research (NASDAQ:NRC) reported earnings of $0.28 per share for the quarter, with a return on equity of 71.33% and a net margin of 17.14%.
• The stock traded at $13.94, with a market cap of $317.62 million and a PE ratio of 13.53.
• Insider Patrick E. Beans increased his stake by buying 2,500 shares, raising his total ownership to approximately $475,690.77.

National Research (NASDAQ:NRC - Get Free Report) issued its earnings results on Monday. The company reported $0.28 earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $34.04 million during the quarter. National Research had a net margin of 12.78% and a return on equity of 76.61%.

National Research Price Performance

Shares of NRC stock traded down $0.02 during trading hours on Friday, reaching $12.49. 21,794 shares of the company were exchanged, compared to its average volume of 91,445. National Research has a fifty-two week low of $9.76 and a fifty-two week high of $26.02. The stock's fifty day moving average is $15.30 and its two-hundred day moving average is $14.67. The company has a market cap of $284.41 million, a price-to-earnings ratio of 16.44 and a beta of 0.45. The company has a debt-to-equity ratio of 1.98, a current ratio of 0.54 and a quick ratio of 0.54.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.12 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.48 dividend on an annualized basis and a yield of 3.8%. National Research's payout ratio is 63.16%.

Insiders Place Their Bets

In related news, major shareholder Patrick E. Beans acquired 2,500 shares of the stock in a transaction dated Monday, May 12th. The stock was bought at an average price of $13.59 per share, with a total value of $33,975.00. Following the completion of the transaction, the insider directly owned 35,003 shares of the company's stock, valued at approximately $475,690.77. The trade was a 7.69% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.10% of the stock is owned by corporate insiders.

Institutional Trading of National Research

A number of hedge funds have recently modified their holdings of the stock. Strs Ohio bought a new stake in National Research during the 1st quarter worth approximately $33,000. Cubist Systematic Strategies LLC bought a new stake in National Research during the 1st quarter worth approximately $118,000. Jane Street Group LLC grew its holdings in National Research by 394.2% during the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company's stock worth $671,000 after acquiring an additional 41,806 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in National Research by 168.6% during the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company's stock worth $1,384,000 after acquiring an additional 67,882 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company's stock.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.